#Cyclohexanols
- The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations
- Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: Results from the CO-MED trial
- Two items on the Hamilton Depression rating scale are effective predictors of remission: Comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine
- Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo
- Efficacy of SSRIs and newer antidepressants in severe depression: Comparison with TCAs